1 / 15

Protein C and Protein S Deficiency

Protein C and Protein S Deficiency. Paolo Aquino 18 February 2003. Hemostasis. The hematologic system is in a balanced flux between pro-coagulant and anti-coagulant factors Imbalance in either direction produces dire consequences: Pro-coagulation: obstruction, stasis  ischemia

Download Presentation

Protein C and Protein S Deficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Protein C and Protein S Deficiency Paolo Aquino 18 February 2003

  2. Hemostasis • The hematologic system is in a balanced flux between pro-coagulant and anti-coagulant factors • Imbalance in either direction produces dire consequences: • Pro-coagulation: obstruction, stasis ischemia • Anti-coagulation: bleeding, blood loss

  3. Protein C • 62-kD vitamin K-dependent glycoprotein • Synthesized in the liver as a single-chain zymogen • Clipped into a serine-protease-like enzyme on phospholipid cell surfaces by thrombin

  4. Protein C • Activated protein C (APC) then binds protein S for further activity • Protein C also has pro-fibrinolytic, anti-inflammatory and anti-ischemic properties

  5. Protein S • Single chain, vitamin K-dependent glycoprotein • Bound state with C4BbP (60%) • Only free state is capable of binding APC (40%)

  6. Protein S • 2 identified genes on chromosome 3 • PROS-a is the active gene • PROS-b is an evolutionarily duplicated non-functional gene

  7. Protein C/Protein S complex • Require negatively charged phospholipids and Ca2+ for normal anti-coagulant activity • Complex acts by proteolyzing Factor VIII and Factor V, which in turn prevents activation of factor X and prothrombin

  8. Deficiency of Protein C and S • Genetic • Autosomal dominant disorders • Homozygous and heterozygous forms • Homozygous form presents in infancy as neonatal purpura fulminans • Heterozygotes generally are not symptomatic until the 3rd and 4th decades

  9. Deficiency of Protein C and S • Acquired • Liver disease • DIC • Vitamin K deficiency • Antagonism with anti-coagulant treatment • Septic shock • Chemotherapy

  10. Symptoms • Deep vein thrombosis is the most common symptomatic manifestation • Pulmonary embolism • Post-phlebitic syndrome • Fetal loss

  11. Lab studies • INR, PT, aPTT • Protein activity level • Protein antigen- total and free • Classification • Type I: decrease in total protein antigen • Type II: decrease in protein activity • Type III: decrease in free protein level

  12. Confounders • Active clotting causes consumption of pro-coagulant and anti-coagulant proteins • Coumadin therapy causes decreased protein activity • Check vitamin K levels • Repeat test on separate specimen

  13. Differential • Anti-thrombin deficiency • DVT • Dysfibrogenemia • Subclavian vein thrombosis • Superficial thrombophlebitis • Anti-phosopholipid syndrome

  14. Treatment • Heparin therapy for a minimum of 5 days with standard protocol • Start Coumadin administration on day 1 or 2 of heparin therapy • Once therapeutic on Coumadin based on INR, can halt heparin therapy • 6-9 months of initial treatment recommended • Controversy regarding lifelong Coumadin therapy

More Related